Akero Therapeutics Inc. (AKRO)
42.66
-0.92 (-2.11%)
At close: Mar 28, 2025, 3:59 PM
42.53
-0.30%
After-hours: Mar 28, 2025, 07:55 PM EDT
Akero Therapeutics Balance Sheet Statement
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
Cash & Equivalents | 340.24M | 234.21M | 249.77M | 150.48M | 187.24M | 136.4M | 75.97M | 598K |
Short-Term Investments | 402.84M | 315.8M | 101.68M | 37.77M | 81.14M | 71.61M | n/a | n/a |
Long-Term Investments | n/a | 19.28M | n/a | n/a | 40K | 40K | 20K | 20K |
Other Long-Term Assets | 54.75M | n/a | 108K | 417K | 161K | 29K | n/a | n/a |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 27.3M | 9.95M | 7.45M | 10.65M | 5.92M | 3.3M | 2.31M | 80K |
Total Current Assets | 770.38M | 559.96M | 355.17M | 193.58M | 271.35M | 138.05M | 77.13M | 638K |
Property-Plant & Equipment | 755K | 1.03M | 1.29M | 1.55M | 1.79M | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 55.51M | 20.31M | 1.4M | 1.97M | 1.99M | 69K | 20K | 20K |
Total Assets | 825.89M | 580.27M | 356.57M | 195.55M | 273.34M | 138.12M | 77.15M | 658K |
Account Payables | 9.03M | 7.04M | 7.97M | 6.71M | 3.43M | 947K | 1.37M | 60K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 631K | 522K | 325K | 205K | 294K | 85K | n/a | n/a |
Other Current Liabilities | 30.1M | 11.57M | 10.79M | 18.22M | 9.39M | 8.34M | 969K | 162K |
Total Current Liabilities | 39.75M | 19.13M | 19.08M | 25.13M | 13.11M | 9.37M | 2.34M | 222K |
Long-Term Debt | 1.06M | 25.78M | 10.62M | 2.62M | 3.03M | n/a | n/a | n/a |
Other Long-Term Liabilities | 34.96M | 54K | 305K | -1.31M | -1.52M | 23K | 124.73M | 5M |
Total Long-Term Liabilities | 36.02M | 25.84M | 10.93M | 1.31M | 1.52M | 23K | 124.73M | 5M |
Total Liabilities | 75.77M | 44.97M | 30.01M | 26.44M | 14.63M | 9.39M | 127.07M | 5.22M |
Total Debt | 529K | 26.3M | 10.95M | 1.52M | 1.81M | n/a | n/a | n/a |
Common Stock | 7K | 6K | 5K | 4K | 4K | 3K | n/a | n/a |
Retained Earnings | -826.16M | -574.1M | -422.34M | -310.3M | -209.53M | -130.32M | -86.56M | -4.56M |
Comprehensive Income | 948K | 270K | 37K | -27K | -3K | -6K | n/a | n/a |
Shareholders Equity | 750.11M | 535.31M | 326.56M | 169.11M | 258.71M | 128.73M | -49.92M | -4.56M |
Total Investments | 402.84M | 335.09M | 101.68M | 37.77M | 81.14M | 71.61M | 20K | 20K |